# Top 50 Biotechnology Startup Investors in Germany in June 2026 ## HTGF (High-Tech Gruenderfonds) - Type: VC Fund - Location: Bonn, Nordrhein-Westfalen, Germany - Relevant deals: 47 - Stages: Seed, Series A - Focus: Software, Biotechnology, Information Technology High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors. ## Boehringer Ingelheim Venture Fund - Type: VC Fund - Location: Ingelheim Am Rhein, Rheinland-Pfalz, Germany - Relevant deals: 18 - Stages: Series A, Series B, Seed - Focus: Biotechnology, Health Care, Therapeutics Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine ## MIG Capital - Type: VC Fund - Location: München, Bayern, Germany - Relevant deals: 16 - Stages: Series A, Series B - Focus: Biotechnology, Health Care, Therapeutics MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies. ## KfW - Type: VC Fund - Location: Frankfurt, Hessen, Germany - Relevant deals: 16 - Stages: Series A, Series B - Focus: Biotechnology, Software, Health Care KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation. ## Bayern Kapital - Type: VC Fund - Location: Landshut, Bayern, Germany - Relevant deals: 15 - Stages: Seed, Series A - Focus: Software, Health Care, Information Technology Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern. ## NRW.BANK - Type: VC Fund - Location: Düsseldorf, Nordrhein-Westfalen, Germany - Relevant deals: 15 - Stages: Seed, Series A, Series B - Focus: Information Technology, Software, Biotechnology NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks. ## Wellington Partners - Type: VC Fund - Location: Munich, Bayern, Germany - Relevant deals: 9 - Stages: Series A, Series B - Focus: Health Care, Biotechnology, Medical Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich. ## b.value AG - Type: VC Fund - Location: Dortmund, Nordrhein-Westfalen, Germany - Relevant deals: 9 - Stages: Seed, Series A - Focus: Biotechnology, Manufacturing, Chemical b.value AG are into Biotechnology investments. ## IFB Innovationsstarter - Type: VC Fund - Location: Hamburg, Hamburg, Germany - Relevant deals: 8 - Stages: Seed, Grant - Focus: Software, SaaS, Artificial Intelligence The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments. ## TGFS - Technologiegründerfonds Sachsen - Type: VC Fund - Location: Leipzig, Sachsen, Germany - Relevant deals: 8 - Stages: Seed, Series A - Focus: Software, Information Technology, Manufacturing TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund. ## BioMedPartners - Type: VC Fund - Location: Basel, Basel-Stadt, Switzerland - Relevant deals: 8 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Medical BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology. ## Techno Venture Management - Type: VC Fund - Location: Boston, Massachusetts, United States - Relevant deals: 7 - Stages: Series B, Series A - Focus: Biotechnology, Health Care, Pharmaceutical Techno Venture Management is a venture capital and private equity firm focused on healthcare industry. ## eCAPITAL ENTREPRENEURIAL PARTNERS - Type: VC Fund - Location: Münster, Nordrhein-Westfalen, Germany - Relevant deals: 6 - Stages: Series A, Series B - Focus: Information Technology, Software, Manufacturing eCAPITAL is a venture capital investor that provides early to growth stage funding to technology and deep tech companies. ## coparion - Type: VC Fund - Location: Cologne, Nordrhein-Westfalen, Germany - Relevant deals: 6 - Stages: Series A, Seed, Series B - Focus: Software, SaaS, FinTech Coparion provides venture capital to accelerate momentum and growth. With a currently active fund of EUR 275 million, Coparion has the means to do so.Coparion supports entrepreneurial vision with know-how, but without intervening in daily business operations. Thanks to in-depth experience in venture capital and in building companies, the Coparionteam discerns potential and opens up new perspectives. Coparion has the substance, tenacity, and creativity required to mutually manage difficult situations successfully.Coparion only invests with co-investors. The fund invests up to EUR 15M per company, usually in several financing rounds of EUR 0.5-8M each. The investment focus is on German companies in the start-up and early growth phases. Coparion is based in Cologne and Berlin. ## Forbion Capital Partners - Type: VC Fund - Location: Naarden, Noord-Holland, The Netherlands - Relevant deals: 6 - Stages: Series B, Series A, Series C - Focus: Biotechnology, Health Care, Medical Impacting the future of medicine. ## bm-t beteiligungsmanagement thuringen - Type: VC Fund - Location: Erfurt, Thuringen, Germany - Relevant deals: 6 - Stages: Seed, Series A - Focus: Software, Information Technology, Health Care bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital. ## bmp Ventures - Type: VC Fund - Location: Berlin, Berlin, Germany - Relevant deals: 6 - Stages: Seed, Series A - Focus: Software, Information Technology, Manufacturing bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises. ## Brandenburg Kapital - Type: VC Fund - Location: Potsdam, Brandenburg, Germany - Relevant deals: 5 - Stages: Seed, Series A - Focus: Software, Information Technology, Health Care With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB). ## Creathor Ventures - Type: VC Fund - Location: Bad Homburg, Hessen, Germany - Relevant deals: 5 - Stages: Series A, Series B - Focus: Software, Health Care, Biotechnology We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed. ## BayBG Venture Capital - Type: VC Fund - Location: München, Bayern, Germany - Relevant deals: 5 - Stages: Series A, Series B - Focus: Software, Information Technology, Health Care Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value. ## IBB Ventures - Type: VC Fund - Location: Berlin, Berlin, Germany - Relevant deals: 5 - Stages: Seed, Series A - Focus: Software, Health Care, SaaS Pre-Seed to Series A for Berlin-based founders. Where 30 years of expertise, capital and execution power meet. ## EMBL Ventures - Type: VC Fund - Location: Heidelberg, Baden-Wurttemberg, Germany - Relevant deals: 5 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Therapeutics EMBL Ventures invest throughout Europe with the aim to build companies that create significant commercial opportunities based on new therapeutic treatment. ## German Federal Ministry of Research, Technology and Space - Type: VC Fund - Location: Bonn, Nordrhein-Westfalen, Germany - Relevant deals: 4 - Stages: Grant, Seed, Series B - Focus: Biotechnology, Medical, Health Care The German Federal Ministry of Research, Technology and Space (BMFTR) funds research programs, promotes in the fields of cutting-edge research, future technologies, innovation and space. ## BlueYard Capital - Type: VC Fund - Location: Berlin, Berlin, Germany - Relevant deals: 4 - Stages: Seed, Series A - Focus: Software, Biotechnology, Internet BlueYard backs founders building the interconnected elements that can become the fabric of our future. ## S-Venture Capital Dortmund - Type: VC Fund - Location: Deutsch, Sachsen, Germany - Relevant deals: 4 - Stages: Series B, Series A - Focus: Biotechnology, Guides, Genetics S-Venture Capital Dortmund aims to fund technology companies and is a German regional investment group. ## Seed Fonds Aachen - Type: VC Fund - Location: Aachen, Nordrhein-Westfalen, Germany - Relevant deals: 4 - Stages: Seed, Series A - Focus: Biotechnology, Medical, Health Care Seed Fonds has a strong competence network with national and international investors, business angels & expertes from the industry. They are specialized in the development of comprehensive financing models offering stability and development opportunities on the long term. ## CPT Capital - Type: VC Fund - Location: London, England, United Kingdom - Relevant deals: 4 - Stages: Series A, Seed, Series B - Focus: Food and Beverage, Biotechnology, Food Processing Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials. ## Grazia Equity - Type: VC Fund - Location: Stuttgart, Baden-Wurttemberg, Germany - Relevant deals: 4 - Stages: Series A, Series B, Seed - Focus: Internet, E-Commerce, Biotechnology Grazia Equity is a venture Capital firm investing in innovative, technology driven startups with high potential.Based in Stuttgart (Germany), Grazia has been supporting a large number of mostly young companies, often from their foundation to the Initial Public Offering or eventual sale. In contrast to other venture capital firms, theypredominantly work with their own capital that they invest as entrepreneurs. ## better ventures - Type: VC Fund - Location: Hamburg, Hamburg, Germany - Relevant deals: 4 - Stages: Pre-Seed, Seed, Series A - Focus: Software, Food and Beverage, E-Commerce At better ventures we invest in early-stage founders who aim to change our world for the better. ## Andera Partners - Type: VC Fund - Location: Paris, Ile-de-France, France - Relevant deals: 4 - Stages: Series B, Private Equity - Focus: Biotechnology, Health Care, Medical Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997. ## Amino Collective - Type: VC Fund - Location: Berlin, Berlin, Germany - Relevant deals: 4 - Stages: Seed, Series A, Pre-Seed - Focus: Health Care, Biotechnology, Medical Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology. ## EIC Fund - Type: VC Fund - Relevant deals: 4 - Stages: Pre-Seed, Seed - Focus: Biotechnology, Health Care, Information Technology start-ups, SMEs, technology, co-investment ## LSP BioVentures - Type: VC Fund - Location: Cambridge, Massachusetts, United States - Relevant deals: 4 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Therapeutics Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek. ## EQT Ventures - Type: VC Fund - Location: Stockholm, Stockholms Lan, Sweden - Relevant deals: 4 - Stages: Series A, Seed, Series B - Focus: Software, Artificial Intelligence, Information Technology EQT Ventures is a European VC fund with just over €2.3 billion in total capital raised. EQT Ventures I launched in May 2016, with commitments totaling €566 million and a simple mission - to be the kind of VC the team would have liked to have had on their own startup journeys. Recognizing that building and growing a company takes more than justcapital, the EQT Ventures team provides founders with support and advice throughout different stages of growth. EQT Ventures doesn't focus on particular markets or industries, but on bold and ambitious founders who have the grit and determination to build global success stories. EQT Ventures II launched in November 2019, with commitments totaling €660 million. EQT Ventures III launched in 2022, with commitments totaling €1.1 billion, making it the biggest European Venture Capital fund committed to early-stage tech startups. The EQT Ventures team is based across six offices in London, Stockholm, Berlin, Paris, Amsterdam, Paris, and San Francisco, taking a locals-with-locals approach and supporting founders on the ground. Motherbrain, EQT Ventures' in-house-developed artificial intelligence (AI) platform, ensures the team has a data-driven approach and has driven more than $100 million in portfolio company investments. ## Counteract - Type: VC Fund - Location: London, England, United Kingdom - Relevant deals: 3 - Stages: Seed, Series A, Pre-Seed - Focus: Environmental Engineering, CleanTech, AgTech Carbon removal innovation through research, development and early stage investment ## Ananda Impact Ventures - Type: VC Fund - Location: Munich, Bayern, Germany - Relevant deals: 3 - Stages: Seed, Series A - Focus: Health Care, Software, Information Technology We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us. ## EQT Life Sciences - Type: VC Fund - Location: Amsterdam, Noord-Holland, The Netherlands - Relevant deals: 3 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Therapeutics Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek. ## TechVision Fund - Type: VC Fund - Location: Aachen, Nordrhein-Westfalen, Germany - Relevant deals: 3 - Stages: Seed, Series A, Pre-Seed - Focus: Software, Health Care, Manufacturing VF-Funds for innovative and scalable start-ups from the Rhineland Area, Germany ## DvH Ventures - Type: VC Fund - Location: Köln, Nordrhein-Westfalen, Germany - Relevant deals: 3 - Stages: Seed, Series A - Focus: Health Care, Financial Services, FinTech Investing early in Europe's most passionate founders. ## Gruenderfonds Ruhr - Type: VC Fund - Location: Essen, Nordrhein-Westfalen, Germany - Relevant deals: 3 - Stages: Series A, Series B, Seed - Focus: Health Care, Biotechnology, Information Technology Gruenderfonds Ruhr is an investment firm. ## Kurma Partners - Type: VC Fund - Location: Paris, Ile-de-France, France - Relevant deals: 3 - Stages: Series A, Seed, Series B - Focus: Health Care, Biotechnology, Medical Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals. ## Agronomics - Type: VC Fund - Location: Douglas, South Lanarkshire, United Kingdom - Relevant deals: 3 - Stages: Series A, Seed, Series B - Focus: Biotechnology, Food and Beverage, Food Processing Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector. ## Elevat3 Capital - Type: VC Fund - Relevant deals: 3 - Stages: Series A, Series B, Post-IPO Equity - Focus: FinTech, Apps, Social Elevat3 Capital is the venture capital arm of serial entrepreneur and investor Christian Angermayer and his family office Apeiron Investment Group. With a focus on German-speaking countries, we partner with companies that meet our three-level criteria, then elevate them by providing more than just capital. We use our exceptional network, spanningindustry, politics, arts, science and technology, to give our portfolio companies access to high-profile leads and advisors, enabling them to grow rapidly and achieve amazing results. ## Taavet Hinrikus - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 3 - Stages: Seed, Series A, Series B - Focus: FinTech, Software, Financial Services Taavet Hinrikus is based out of London, England and is the Partner of Plural Platform and Board Member of CoMind. Taavet previously worked at Wise as a Chairman and Co-founder. Taavet Hinrikus attended INSEAD. ## TVM Capital - Type: VC Fund - Location: Munich, Bayern, Germany - Relevant deals: 3 - Stages: Series B, Series C - Focus: Biotechnology, Health Care, Pharmaceutical TVM Capital Life Science is one of the transatlantic Venture Capital pioneers with teams based in North America and Europe. ## Think.Health - Type: VC Fund - Location: Fürstenfeldbruck, Bayern, Germany - Relevant deals: 3 - Stages: Seed, Series A, Series B - Focus: Health Care, Biotechnology, Medical Device Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers, ## Andrew Keys - Type: Angel - Relevant deals: 3 - Stages: Seed, Pre-Seed, Series A - Focus: Software, Finance, Blockchain Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland. ## OCCIDENT - Type: VC Fund - Location: Zug, Zug, Switzerland - Relevant deals: 3 - Stages: Series A, Series B, Series C - Focus: Health Care, Biotechnology, Medical Device Occident is an international, privately held investment company based in Zug and Munich. Our goal is to manage our own wealth in a sustainable, meaningful manner seeking to make a positive contribution to society through our investments. Venture Capital is the focus of our investment activities. We see ourselves as a long-term oriented enabler forinnovative start-ups and visionary founders. As a complementary team of experts, we are fascinated by technologically sound topics (deep tech) from the life sciences, digital and high-tech sectors with the potential to decisively improve people's lives. ## Good Seed Ventures - Type: VC Fund - Location: Rheine, Nordrhein-Westfalen, Germany - Relevant deals: 3 - Stages: Seed, Series A, Pre-Seed - Focus: Food and Beverage, Food Processing, Biotechnology Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech. ## M Ventures - Type: VC Fund - Location: Amsterdam, Noord-Holland, The Netherlands - Relevant deals: 3 - Stages: Series A, Series B, Seed - Focus: Biotechnology, Health Care, Therapeutics Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.